Anteilseigner
Farallon Capital Management LLC (9,85 %) RTW Investments LP (9,12 %) BlackRock Fund Advisors (7,08 %) SSgA Funds Management, Inc. (5,62 %) The Vanguard Group, Inc. (5,27 %) Johnson & Johnson Innovation - JJDC, Inc. (4,20 %) Bain Capital Life Sciences LP (4,06 %) Adage Capital Management LP (3,81 %) Morgan Stanley & Co. LLC (3,12 %) Geode Capital Management LLC (2,22 %) Point72 Asset Management LP (2,06 %) Jefferies Investment Advisers LLC (2,03 %) Kynam Capital Management LP (1,96 %) BlackRock Advisors LLC (1,73 %) Perceptive Advisors LLC (1,71 %) Marshall Wace LLP (1,68 %) Fairmount Funds Management LLC (1,60 %) DWS Investments (UK) Ltd. (1,41 %)
Kontakt
Protagonist Therapeutics Inc.